RPRX - Royalty Pharma Plc - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RPRX is currently covered by 6 analysts with an average price target of $62. This is a potential upside of $5.07 (8.91%) from yesterday's end of day stock price of $56.93.

Royalty Pharma Plc's activity chart (see below) currently has 101 price targets and 84 ratings on display. The stock rating distribution of RPRX is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.74% with an average time for these price targets to be met of 638.64 days.

Highest price target for RPRX is $66, Lowest price target is $57, average price target is $62.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 07-May-2026.

Currently out of the existing stock ratings of RPRX, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Jul-2020

$66

$13.15 (24.88%)

$50

5 months 4 days ago
(07-May-2026)

7/9 (77.78%)

$15.8 (31.47%)

541

Buy Since 21-Apr-2026

$57

$4.15 (7.85%)

$38

5 months 20 days ago
(21-Apr-2026)

7/8 (87.5%)

$7.52 (15.20%)

642

Buy Since 08-Aug-2022

$63

$10.15 (19.21%)

$56

6 months 1 days ago
(10-Apr-2026)

15/23 (65.22%)

$15.1 (31.52%)

981

Buy Since 13-Jul-2020

$42

$-10.85 (-20.53%)

$42

1 years 29 days ago
(12-Sep-2025)

3/4 (75%)

$6.03 (16.76%)

418

Buy Since 28-Jul-2022

$40

$-12.85 (-24.31%)

$60

1 years 11 months 16 days ago
(25-Oct-2024)

3/4 (75%)

$14.06 (54.20%)

1371

Show more analysts

Please expand the browser size to see the chart

What is RPRX (Royalty Pharma Plc) average time for price targets to be met?

On average it took 639 days for the stock forecasts to be reached, with an average price target met ratio of 44.74%.

Which analyst most recently updated their price target on RPRX (Royalty Pharma Plc)?

Geoff Meacham

Which analyst has the most public recommendations on RPRX (Royalty Pharma Plc)?

Geoff Meacham works at CITI and has 3 price targets and 1 ratings on RPRX

Which analyst is the currently most bullish on RPRX (Royalty Pharma Plc)?

Geoff Meacham with the highest potential upside of $13.15

Which analyst is the currently most reserved on RPRX (Royalty Pharma Plc)?

Andrew Baum with the lowest potential downside of -$12.85
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?